Purification of untagged HIV-1 reverse transcriptase by affinity chromatography

• Published in: Protein expression and purification Vol. 71; no. 2; pp. 231 - 239
• Main Authors: Lu, Meiqing, Ngo, Winnie, Mei, Ye, Munshi, Vandna, Burlein, Christine, Loughran, Marie H., Williams, Peter D., Hazuda, Daria J., Miller, Michael D., Grobler, Jay A., Diamond, Tracy L., Lai, Ming-Tain
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2010
• Subjects: Affinity chromatography; Affinity chromatography: RNase H; Antiviral Agents - pharmacology; Antiviral Agents - therapeutic use; Base Sequence; Chromatography, Affinity - methods; Genetic Vectors - drug effects; HIV Reverse Transcriptase - genetics; HIV Reverse Transcriptase - isolation & purification; HIV Reverse Transcriptase - metabolism; HIV-1; HIV-1 - drug effects; HIV-1 - genetics; Human immunodeficiency virus 1; Humans; Reverse transcriptase; Ribonuclease H - genetics; HIV-1; Affinity chromatography: RNase H; Reverse transcriptase
• DOI: 10.1016/j.pep.2010.01.001
• ISSN: 1046-5928

Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) plays an essential role in the life cycle of the virus. Therefore, RT has been a primary target in the development of antiviral agents against HIV-1. Given the prevalence of resistant viruses, evaluation of the resistance profile of potential drug candidates is a key step in drug development. A simplified RT purification protocol would facilitate this process, as it provides an efficient method by which to purify RT variants for compound evaluation. Traditional purification protocols require the use of several columns to purify untagged RT. The entire procedure usually requires at least one week to complete. Herein, we report two novel methods that enable us to purify highly active RT in either one or two steps. First, a one-step purification protocol was developed by employing an affinity column that was prepared by conjugating an RNase H specific inhibitor (RNHI) with NHS-activated resin. Cell lysate containing RT was loaded onto the column followed by washing in the presence of 2 mM Mn 2+. The RT retained in the column was eluted after soaking overnight in 10 mM EDTA to retrieve the Mn 2+. In the other method, a vector was constructed that encodes RT fused to cleavable intein and AviTag (a biotin tag) sequences at the C-terminus. Cell lysate containing biotinylated RT was passed through a DE-52 column and then loaded onto an avidin column. Untagged RT was released from the column by reductive cleavage of the intein by DTT. These two methods significantly shorten the time required to purify untagged WT and mutant RTs.